Melinta Therapeutics, Inc. (NASDAQ:MLNT)

6.93
Delayed Data
As of 11:06am ET
 -0.025 / -0.36%
Today’s Change
6.50
Today|||52-Week Range
24.25
-56.17%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Melinta Therapeutics, Inc. have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a +116.61% increase from the last price of 6.93.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Melinta Therapeutics, Inc.. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$4.20
Sales
$6.4M
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -183.45%
 
 
 
 
 
 
Growthannually 78.42%
 
 
 
 
 
 

Sales

Growthquarterly 52.35%
 
 
 
 
 
 
Growthannually 102.02%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.